Nomogram model including LATS2 expression was constructed to predict the prognosis of advanced gastric cancer after surgery

Table 1 Clinical information, n (%)

Characteristics	All patients cases (%)/median (IQR)	Training group cases (%)/median (IQR)	Validation group cases (%)/median (IQR)	P value
Sex
Male	197 (80.41)	142 (83.04)	55 (74.32)	0.16
Female	48 (19.59)	29 (16.96)	19 (25.68)
Age
< 65	98 (40.00)	64 (37.43)	34 (45.95)	0.27
≥ 65	147 (60.00)	107 (62.57)	40 (54.05)
Hypertension
No	159 (64.90)	115 (67.25)	44 (59.46)	0.30
Yes	86 (35.10)	56 (32.75)	30 (40.54)
Diabetes
Yes	23 (9.39)	13 (7.60)	10 (13.51)	0.22
No	222 (90.61)	158 (92.40)	64 (86.49)
Chronic lung disease
Yes	9 (3.67)	6 (3.51)	3 (4.05)	1
No	236 (96.33)	165 (96.49)	71 (95.95)
Smoking
Yes	223 (91.02)	154 (90.06)	69 (93.24)	0.58
No	22 (8.98)	17 (9.94)	5 (6.76)
Lymphatic invasion
Yes	200 (81.63)	140 (81.87)	60 (81.08)	1
No	45 (18.37)	31 (18.13)	14 (18.92)
LATS2
High	164 (66.90)	121 (70.70)	43 (58.10)	0.60
Low	81 (33.10)	50 (29.30)	31 (41.80)
Alcohol consumption
Yes	135 (55.10)	93 (54.39)	42 (56.76)	0.84
No	110 (44.90)	78 (45.61)	32 (43.24)
Tumor size
> 5 cm	205 (83.67)	145 (84.80)	60 (81.08)	0.59
≤ 5 cm	40 (16.33)	26 (15.20)	14 (18.92)
T stage
2	45 (18.37)	26 (15.20)	19 (25.68)	0.11
3	23 (9.39)	15 (8.77)	8 (10.81)
4	177 (72.24)	130 (76.03)	47 (63.51)
N stage
0	74 (30.20)	54 (31.58)	20 (27.03)	0.62
1	45 (18.37)	28 (16.37)	17 (22.97)
2	51 (20.82)	35 (20.47)	16 (21.62)
3	75 (30.61)	54 (31.58)	21 (28.38)

IQR: Interquartile range.